The concentrations of serum calcium, parathyroid hormone (PTH), 25 Hydroxyvitamin D (250HD), and 1,25 Dihydroxyvitamin D (1,25(OH}zD) were determined in 99 Saudi patients with sickle cell disease and in 104 matching healthy controls. Serum calcium and 250HD were significantly lower in the patients, with 140/0 and 12% of them had serum calcium and 250HD concentrations, respectively, below the normal range. PTH was significantly higher in the patients, with 31% having values above the normal range. There was no significant difference between patients and controls in regard to 1,25(OH}zD. There was a significant inverse correlation of 250HD with PTH and a direct correlation of PTH with 1,25(OH}zD. Dietary intake of calcium and vitamin D was adequate in both patients and controls. The results indicate that sickle cell patients have hypocalcaemic tendency associated with supranormal PTH, and imply impaired intestinal absorption of calcium and vitamin D leading to a disturbed calcium metabolism which might contribute to the skeletal changes seen in sickle cell disease.
Vitamin D synthesized in the skin and absorbed in the intestine, undergoes metabolic transformations before exerting its effect on target tissues.1,2 It is hydroxylated in the liver producing the predominant inactive form, 25 hydroxyvitamin D (250HD), which is further hydroxylated in the kidney producing the metabolically active form, 1,25 dihydroxyvitamin D (l,25(OH}zD.3-S Parathyroid hormone (PTH) and 1,25(OHhD play an essential role in calcium and phosphorus homeostasis, which is achieved by their action on the target organs (intestine, bone and kidney), leading ultimately to normal bone formation and mineralization, and also normal physiological concentrations of plasma calcium and phosphorus. Any alteration in these hormones may lead to disturbance in the calcium homeostasis, which may result in metabolic bone disorders.
Pathophysiological changes of the skeletal system are among the most common features of Correspondence: Dr Samir Mohammed. sickle cell disease (SCD). These changes might occur at any part of the skeletal system, and could be in the form of osteoporosis, bone marrow hyperplasia, thinning of the bone cortex, and changes that lead to pathological fractures. These changes are attributed to the repeated infarctions resulting from the sickling process within the skeletal system. The role and the status of calcium metabolism and its possible involvement in the pathophysiology of the bone changes in the disease has not been reported, except for only few indirect reports on the status of calcium and PTH in a very small number of patients.s-'? In most cases the concentrations of serum calcium ranged from normal to lower than normal, with an altered renal handling of calcium and phosphorus in some sickle cell patients (SCP).6.7.9.10 Parathyroid gland abnormalities have also been reported in a very small number of patients." No reports are available on the status of vitamin D and its metabolites in this disease, although various organs which are directly or indirectly involved in vitamin D metabolism are affected. Liver cell injury,11 abnormal production and formation of bile,12-16 gallstone formation,ll.12,17 intestinal malabsorption of various dietary products,18-22 and the many well-known renal abnormalities in SCD may affect absorption and synthesis of vitamin D and its metabolites.
The few existingreports on the status of calcium and PTH in SCD, together with the various digestive and absorptive malfunctions reported by many investigators, strongly suggest the possibility of a disturbed calcium metabolism in SCD. This disturbance, in addition to the sickling process, may contribute to the skeletal changes of the disease. This study investigates some aspects of calcium metabolism in Saudi patients with SCD, by measuring the plasma concentrations of calcium, PTH, and vitamin D metabolites.
MATERIALS AND METHODS
Ninety-nine Saudi SCD patients of both sexes (55 males and 44 females) aged 5-25 years were investigated. All the patients (Hb SS) were regular attendants of the sickle cell clinics in the Southern region of Saudi Arabia. All werein non-crisissteady state and had not been transfused for the past 4 months. One hundred and four healthy matching controls (49 males and 55 females) aged 5-25 years were alsoinvestigated. The controls (Hb AA) were either siblings or relatives of the patients.
All were symptom-free at the time of study. The patients and the controls were divided into three age groups: 5-10, 11-15, and 16-25 years. Neither the patients nor the controls were taking any vitamin D supplements. Diet and exposure to sunlight were the main sources of vitamin D.
Fasting blood samples were collected in vacutainer tubes, and the serum was separated and stored at -30 cC until the time of analysis. Serum calcium was measured using clinical autoanalyser (Hitachi 704). PTH was measured according to the procedure of a commercially available radioimmunoassay kit (DiagnosticSystemsLaboratories Inc., Webster, Texas, USA), which is specific for the quantitative measurement of the intact and the mid-molecule fragment of human PTH. The results are expressed in pmol/L. In the serum samples, 25(OH)D and 1,25(OHhD were also measured using commercially available radioimmunoassay kits (INCSTAR Corp, Minnesota, USA). These kits are specific for the quantitative measurement of both forms of vitamin D (cholecalciferol and ergocalciferol), and assays were performed and calculated according to the manufacturer's instruction. The concentrations of 25(OH)D and l,25(OHhD were expressed in ng/mL and pg/mL, respectively. The precision of the assay methods were determined by analysing a normal human serum sample. The intra-assay CVs of the methods used were 5'7010, 6'4%, and 9'3% and the inter-assay CVs were 4'5%,7'40/0, and 8'2% for PTH, 250HD, and 1,25(OHhD, respectively. The daily dietary intake of vitamin D and calcium by sickle cell patients and controls was assessed using a food frequency questionnaire and dietary recall interviews.
Statistical analysis was done using Student's ttest. P values < 0·05 were considered significant using two-tailed significant level. Regression equation and the correlation factor was calculated using the method of least squares.
RESULTS
Initial analysis of the data in this study showed no significant sex differences in the mean values of either the patients or the controls. Therefore, the results in all tables and figures are presented regardless of sex. Serum concentration of vitamin D, PTH, and calcium are shown in Table 1 . The table shows that SCP have significantly lower mean values of serum calcium and 250HD (P<O·ool and 0'01, respectively) and significantly higher mean values of PTH (P<O·ool) of the three age groups. The mean values of I ,25(OH) 2D are significantly higher in the patients only in the second age group, while slightly higher, but not significantly, in the other age groups. Table 1 also shows no increase or decrease of all parameters with age in either the patients or the controls. Table 2 shows the numbers and percentages of SCP with values either lower or higher than the normal range of the measured parameters. It is clear from the table that about one-third of SCP (31%) have PTH values greater than the upper normal range. 8% have 1,25(OHhD values above the upper normal range, while 12% and 14% have values below the lower normal range in 250HD and calcium, respectively.
According to the concentrations of PTH, the SCP were divided into two groups: Group A with PTH values greater than 100 pmol/L, and Group B with PTH values less than 100 pmollL. Comparison of the biochemical findings in these two groups is shown in Table 3 . The table clearly shows a significant difference between the two groups regarding the levels of 250HD, 1,25(OHhD, and PTH. There is no significant difference regarding the levels of calcium.
Correlation of PTH with calcium, 250HD, and 1,25(ODhD, in all SCP, are presented in Figs 1, 2 and 3. Figure 1 shows a scatterplot of serum calcium with PTH. This figure clearly shows the 
DISCUSSION
The results presented show the concentrations of some of the biochemical parameters related to calcium metabolism in SCD. There were no sex or age differences in these concentrations in either the controls or the patients. Although the mean values of the investigated parameters were significantly different in the SCP compared to the controls, most of the values of the measured parameters in the SCP were either closer to the lower limit (as in the case of calcium and 250HD) or closer to the upper limit (as in the case of PTH and 1,25(OH) 2D) of the normal reference ranges of our laboratory (Calcium: 2'15-2,65 mmollL, PTH: 45-100 pmollL, 250HD: 10-38 ng/rnl., and 1,25(OHhD 18-42 pg/mL). However, some of the studied SCP had values outside the limits of these normal ranges ( Table 2 ). Thirty-one patients (31070) had PTH values above the upper limit of the normal range, compared to only 2070 in the controls. It is also observed that many of the patients (approximately 28070) had low normal or 'just normal' concentrations of serum calcium (Fig. 1) . This indicates their tendency to hypocalcaemia, which is also clearly evident in Our dietary recall interviews and food frequency questionnaires indicated that the daily intake of calcium and vitamin D (mainly in the form of milk and milk-products) was adequate. The estimated mean and (range) of the daily intake of calcium was 1017 mg (700-1350) in SCP and 1323 mg (850-1500) in the controls, and approximately 400 IV (200-600) of vitamin D in both. approximately 140/0 of the patients, where serum calcium is below the normal range ( Table 2 and Fig. 1 ). Such findings were not exhibited in the controls.
The mean values of 250HD and 1,25(OHhD were within the normal range except for 12% of the studied patients (5 males and 7 females) who had 250HD values below normal range, and 8% who had l,25(OH) 2D values above the normal range compared to 2% and 3% in the controls, respectively. The significant inverse correlations of 250HD with PTH and the direct correlation of PTH with 1,25(OHhD (Figs 2 and 3 ) which were not observed in the controls, demonstrate an altered vitamin D and PTH metabolism. Furthermore, patients with high concentrations of PTH (Table 3 , Group A) had significantly lower values of 250HD but higher values of 1,25(OHhD than in Group B. Out of the 12 SCP with the low 250HD levels, 9 were within Group A, and out of the 8 with high l,25(OH)2D, 7 were in this group also. These findings are supported by the significant correlations found between PTH and vitamin D metabolites. There was no significant difference in the concentration of serum calcium between the two groups. However, of the previously indicated 14% with low serum calcium, only 4% were within Group A.
As mentioned earlier, the status of vitamin D metabolism is not known in SCD and to the best of our knowledge not been investigated before. However, very few reports had indirectly and briefly dealt with the status of calcium and PTH in a very small number of patients.v!" Normal serum calcium associated with decreased renal excretion of calcium was reported in some patients," while moderate and true hypocalcaemia was reported in others. 7,9,10 High PTH levels and abnormal parathyroid gland, had been reported in SCP with advanced renal failure. 7,s The frank hypocalcaemia observed by some investigators? although clearlysuggestingan altered calcium metabolism in their patients was not commented upon. Only one group of investigators strongly suggested the investigation of PTH status in SCD.6 Therefore, these reports and our findings reported in this study regarding the hypocalcaemic tendency, the elevated PTH, and the low 250HD concentrations, strongly support the suggested possibility of a disturbed calcium metabolism in SCD.
Although dietary intake of calcium and vitamin D (in the form of milk and milk-products) by both SCP and controls were adequate, some of the studied patients had an altered status of calcium and vitamin D metabolites. Therefore, subnormal dietary calcium and vitamin D intake neither explain the hypocalcaemic tendency nor the low levelsof 250HD. Hence, it is possible that intestinal absorption of calcium and vitamin D is impaired in some of the patients which agrees with previous reports of abnormal digestive and absorptive functions in SCD. 1S-24 Abnormal absorption of fat and fat-soluble materials such as vitamin E,22,23 increased faecal fat excretion associated with bulky stooI,23,24 abnormal d-Xylose absorption test,20,21 protein malabsorption.l? and duodenal ulceration and infarction of the intestinal mucosal cell 23, 26 have been reported. It is also well known that non-sickle cell patients suffering from fat malabsorption, usually have poor absorption of calcium and vitamin D, and increased faecal excretion of 250HD. 27,2S With all of the above mentioned abnormalities in SCD, it is likely that digestive and the absorptive function is impaired, which would explain the low serum calcium and vitamin D observed in some of the studied SCP.
The low levels of 250HD seen in our patients might also be due to the various well-known malfunctions and structural changes of the liver in SCD,u-17 These changes might affect the rate of the hydroxylation step of vitamin D which may lead to a decreased concentration of 250HD in the blood. Non-sickle cell patients with cirrhosis of the liver have been reported to have low 250HD attributable to either malabsorption or defective hepatic conversion of vitamin D to 250HD. 29 Such abnormality may actually well occur in SCP.
Previous reports on the status of vitamin D in normal subjects from the Eastern region of Saudi Arabia (Riyadh area) had indicated that Saudis, especially the elderly, had low levels of 250HD, with no differences between males and females. [30] [31] [32] The low levels were attributed to low dietary intake of vitamin D (55 IV/day) and also due to avoidance of sunlight, and not to the clothing style of the Saudi population. 30,32 The patients and controls investigated in this study were mainly from the rural area of the Southern region of Saudi Arabia, where the chances for sunlight exposure is much greater than the Riyadh area. Furthermore, the dietary intake of vitamin D by our patients and controls was adequate, therefore, they have higher values of 250HD than those from the Eastern region, except for the 12% of SCP with low values of 250HD. Since SCP are often ill and confined indoors, it is possible that they are less exposed to sunlight than their normal counterparts, therefore, have low vitamin D store (250HD).
In spite of the various well-known renal abnormalities in SCD, the results of this study indicate that the patients have undisturbed renal synthesis of I ,25(OH}zD. The slightly elevated levels of 1,25(OH}zD observed in some of the patients in our study might be due to the elevated concentrations of PTH, which is dearly evident by the direct correlation shown in Fig. 3 .
It can be concluded that more than one factor is playing a role in the disturbance of calcium and vitamin D metabolism seen in our patients. However, the digestiveand absorptive malfunctions may remain the major ones. One would infer that in SCP the disturbance in calcium metabolism might be initiated by poor intestinal absorption of calcium and vitamin D. The impaired calcium absorption leads to decreased ionized calcium in the plasma, which in turn stimulates the secretion of PTH in an attempt to correct the disturbance. The elevated levels of PTH in our patients may be seen as appropriate resulting from the physiological adjustment in response to a hypocalcaemic tendency. As shown in Fig. 1, calcium control system in the majority of the patients was operating adequately, most probably at the expense of bone to maintain blood calcium level normal or 'just normal'. The 'just normal' levels of calcium observed in our patients may also be achieved in part by the increased renal conservation of calcium, which was observed by other investigators," due to the action of PTH. The elevated levels of PTH would also stimulate the hydroxylation of 250HD in the kidney to form 1,25(OHhD, which in turn stimulates intestinal absorption of vitamin D and calcium. The net result of these processes is to maintain normal serum calcium. If, however, the gastrointestinal absorption of calcium remains insufficient, physiological adjustments would be required to maintain normal serum calcium, which will be achieved mainly by the increased bone resorption, and in consequence, the bone structure will suffer. Since the investigated patients in this study were children and young adults, their clinico-physiological features, especially bone changes are not so severe or prominent as those of older patients. Therefore, we believe that more investigations into the status of calcium metabolism are needed in SCD, especially in older patients.
